Two Sigma Advisers
PAND

Two Sigma Advisers’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Two Sigma Advisers’s Portfolio PAND Stock Details PAND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,700
Closed -$883K – 2828
2021
Q1 		$883K Sell
14,700
-14,200
-49% -$514K ﹤0.01% 1723
2020
Q4 		$429K Sell
28,900
-6,700
-19% -$93.2K ﹤0.01% 1921
2020
Q3 		$408K Buy
+35,600
New +$608K ﹤0.01% 1897

Two Sigma Advisers's PAND Position: Q2 2021 in Review

Two Sigma Advisers sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 14,700 shares — an estimated $883K sold.

Two Sigma Advisers first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $883K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • Two Sigma Advisers reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Two Sigma Advisers sold 14,700 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $883K.
  • Two Sigma Advisers first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Two Sigma Advisers's Pandion Therapeutics Inc. Common Stock position peaked at $883K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Two Sigma Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.